AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Garkavtsev, IV Kley, N Grigorian, IA Gudkov, AV
Citation: Iv. Garkavtsev et al., The Bloom syndrome protein interacts and cooperates with p53 in regulationof transcription and cell growth control, ONCOGENE, 20(57), 2001, pp. 8276-8280

Authors: Kwek, SSS Derry, J Tyner, AL Shen, ZY Gudkov, AV
Citation: Sss. Kwek et al., Functional analysis and intracellular localization of p53 modified by SUMO-1, ONCOGENE, 20(20), 2001, pp. 2587-2599

Authors: Bacus, SS Gudkov, AV Lowe, M Lyass, L Yung, Y Komarov, AP Keyomarsi, K Yarden, Y Seger, R
Citation: Ss. Bacus et al., Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53, ONCOGENE, 20(2), 2001, pp. 147-155

Authors: Kondratov, RV Komarov, PG Becker, Y Ewenson, A Gudkov, AV
Citation: Rv. Kondratov et al., Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein, P NAS US, 98(24), 2001, pp. 14078-14083

Authors: Neznanov, N Kondratova, A Chumakov, KM Angres, B Zhumabayeva, B Agol, VI Gudkov, AV
Citation: N. Neznanov et al., Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from cell surface, J VIROLOGY, 75(21), 2001, pp. 10409-10420

Authors: Skowyra, D Zeremski, M Neznanov, N Li, MY Choi, YM Uesugi, M Hauser, CA Gu, W Gudkov, AV Qin, J
Citation: D. Skowyra et al., Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex, J BIOL CHEM, 276(12), 2001, pp. 8734-8739

Authors: Komarova, EA Gudkov, AV
Citation: Ea. Komarova et Av. Gudkov, Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors, BIOCH PHARM, 62(6), 2001, pp. 657-667

Authors: Botchkarev, VA Komarova, EA Siebenhaar, F Botchkareva, NV Sharov, AA Komarov, PG Maurer, M Gudkov, AV Gilchrest, BA
Citation: Va. Botchkarev et al., p53 involvement in the control of murine hair follicle regression, AM J PATH, 158(6), 2001, pp. 1913-1919

Authors: Komarova, EA Christov, K Faerman, AI Gudkov, AV
Citation: Ea. Komarova et al., Different impact of p53 and p21 on the radiation response of mouse tissues, ONCOGENE, 19(33), 2000, pp. 3791-3798

Authors: Rokhlin, OW Gudkov, AV Kwek, S Glover, RA Gewies, AS Cohen, MB
Citation: Ow. Rokhlin et al., p53 is involved in tumor necrosis factor-alpha-induced apoptosis in the human prostatic carcinoma cell line LNCaP, ONCOGENE, 19(15), 2000, pp. 1959-1968

Authors: Botchkarev, VA Komarova, EA Siebenhaar, F Botchkareva, NV Komarov, PG Maurer, M Gilchrest, BA Gudkov, AV
Citation: Va. Botchkarev et al., p53 is essential for chemotherapy-induced hair loss, CANCER RES, 60(18), 2000, pp. 5002-5006

Authors: Komarova, EA Gudkov, AV
Citation: Ea. Komarova et Av. Gudkov, Suppression of p53: a new approach to overcome side effects of antitumor therapy, BIOCHEM-MOS, 65(1), 2000, pp. 41-48

Authors: Stark, GR Gudkov, AV
Citation: Gr. Stark et Av. Gudkov, Forward genetics in mammalian cells: functional approaches to gene discovery, HUM MOL GEN, 8(10), 1999, pp. 1925-1938

Authors: Komarov, PG Komarova, EA Kondratov, RV Christov-Tselkov, K Coon, JS Chernov, MV Gudkov, AV
Citation: Pg. Komarov et al., A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy, SCIENCE, 285(5434), 1999, pp. 1733-1737

Authors: Zeremski, M Hill, JE Kwek, SSS Grigorian, IA Gurova, KV Garkavtsev, IV Diatchenko, L Koonin, EV Gudkov, AV
Citation: M. Zeremski et al., Structure and regulation of the mouse ing1 gene - Three alternative transcripts encode two PHD finger proteins that have opposite effects on p53 function, J BIOL CHEM, 274(45), 1999, pp. 32172-32181

Authors: Ermakova, A Anikeev, VI Gudkov, AV
Citation: A. Ermakova et al., Thermodynamic analysis of the phase states of the Fischer-Tropsch reactionproducts, RUS J AP CH, 71(11), 1998, pp. 1885-1892

Authors: Komarova, EA Gudkov, AV
Citation: Ea. Komarova et Av. Gudkov, Could p53 be a target for therapeutic suppression?, SEM CANC B, 8(5), 1998, pp. 389-400
Risultati: 1-17 |